Akzo Nobel N V S/Adr
(AKZOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,302,340 | 2,786,770 | 2,253,240 | 2,277,550 | 3,786,120 |
| Receivables | 3,646,260 | 3,368,560 | 3,469,890 | 4,063,380 | 3,702,460 |
| Inventories | 2,053,760 | 1,894,150 | 1,987,020 | 2,680,130 | 2,228,380 |
| Other current assets | 204,730 | 383,890 | 1,301,550 | 136,520 | 143,440 |
| TOTAL | $8,207,090 | $8,433,370 | $9,011,700 | $9,157,580 | $9,860,400 |
| Non-Current Assets | |||||
| PPE Net | 5,097,860 | 4,767,260 | 4,808,720 | 5,161,060 | 4,493,950 |
| Investments And Advances | 243,260 | 0 | 0 | 275,810 | 0 |
| Other Non-Current Assets | 8,118,030 | 8,135,820 | 9,281,770 | 13,083,040 | 12,330,470 |
| TOTAL | $13,459,150 | $12,903,080 | $14,090,490 | $18,519,910 | $16,824,420 |
| Total Assets | $21,666,260 | $21,336,480 | $23,102,210 | $27,677,510 | $26,684,830 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,528,920 | 4,274,460 | 4,169,530 | 2,837,540 | 4,389,040 |
| Accrued Expenses | 301,750 | 0 | 0 | 891,520 | 0 |
| Other current liabilities | 671,290 | 1,155,620 | 1,485,440 | 2,278,940 | 1,393,070 |
| TOTAL | $6,580,030 | $6,706,580 | $6,506,370 | $6,696,150 | $6,986,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,359,140 | 3,541,240 | 4,357,300 | 4,227,750 | 3,824,640 |
| Other Non-Current Liabilities | 2,848,680 | 3,090,950 | 2,776,679 | 2,391,780 | 3,245,630 |
| TOTAL | $6,755,490 | $6,632,190 | $7,133,979 | $7,409,360 | $7,070,270 |
| Total Liabilities | $13,335,530 | $13,338,780 | $13,640,370 | $14,105,510 | $14,056,880 |
| Shareholders' Equity | |||||
| Common Shares | 654,010 | 644,220 | 614,750 | 653,310 | 620,170 |
| Retained earnings | 6,509,580 | 0 | 0 | 12,120,490 | 11,298,620 |
| Other shareholders' equity | 551,670 | 6,929,750 | 8,623,300 | 732,720 | 697,210 |
| TOTAL | $8,330,720 | $7,997,690 | $9,461,830 | $13,571,990 | $12,627,950 |
| Total Liabilities And Equity | $21,666,250 | $21,336,470 | $23,102,200 | $27,677,500 | $26,684,830 |